Stock Information
Immix Biopharma Inc (IMMX)
Ticker Symbol: IMMX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $473.50 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.8771
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -101.24%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Immix Biopharma, Maintains $15 Price Target
Mon, Mar 30, 2026 1:33 PM
-
Mizuho Maintains Outperform on Immix Biopharma, Raises Price Target to $15
Mon, Mar 30, 2026 10:07 AM
-
Immix Biopharma Announces Achieved Enrollment Targets For NEXICART-2 AL Amyloidosis Treatment Study; Results Expected Q3 2026
Mon, Mar 30, 2026 8:47 AM
Key Financials
Financial data not available
